AGIOS PHARMACEUTICALS, INC. financial data

Symbol
AGIO on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1417% % 34%
Quick Ratio 45% % 40%
Debt-to-equity 7.5% % -33%
Return On Equity -31% % -153%
Return On Assets -29% % -154%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58,592,172 shares 2.3%
Common Stock, Shares, Outstanding 58,448,592 shares 2.3%
Entity Public Float $1,914,339,201 USD -21%
Weighted Average Number of Shares Outstanding, Basic 57,972,004 shares 2%
Weighted Average Number of Shares Outstanding, Diluted 57,972,004 shares 0.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $54,028,000 USD 48%
Research and Development Expense $339,535,000 USD 13%
Costs and Expenses $526,160,000 USD 14%
Operating Income (Loss) $472,132,000 USD -11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $103,433,000 USD -110%
Income Tax Expense (Benefit) $0 USD -100%
Net Income (Loss) Attributable to Parent $412,781,000 USD -161%
Earnings Per Share, Basic -7.12 USD/shares -160%
Earnings Per Share, Diluted -7.12 USD/shares -161%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $89,130,000 USD 17%
Cash, Cash Equivalents, and Short-term Investments $1,200,000,000 USD -20%
Inventory, Net $32,920,000 USD 19%
Assets, Current $942,052,000 USD -2.4%
Property, Plant and Equipment, Net $10,775,000 USD -7.7%
Operating Lease, Right-of-Use Asset $30,454,000 USD -29%
Other Assets, Noncurrent $3,931,000 USD -17%
Assets $1,297,225,000 USD -22%
Accounts Payable, Current $18,355,000 USD 10%
Employee-related Liabilities, Current $27,264,000 USD -8.9%
Accrued Liabilities, Current $45,459,000 USD -3%
Liabilities, Current $82,206,000 USD 1.3%
Operating Lease, Liability, Noncurrent $21,815,000 USD -46%
Other Liabilities, Noncurrent $90,000 USD -90%
Liabilities $104,111,000 USD -15%
Retained Earnings (Accumulated Deficit) $561,705,000 USD -277%
Stockholders' Equity Attributable to Parent $1,193,114,000 USD -23%
Liabilities and Equity $1,297,225,000 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $111,489,000 USD -12%
Net Cash Provided by (Used in) Financing Activities $1,619,000 USD -72%
Net Cash Provided by (Used in) Investing Activities $112,587,000 USD -9.6%
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Shares, Issued 74,665,003 shares 1.8%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,717,000 USD -91%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $89,130,000 USD 17%
Deferred Tax Assets, Valuation Allowance $365,623,000 USD 33%
Deferred Tax Assets, Gross $373,534,000 USD 30%
Operating Lease, Liability $40,207,000 USD -29%
Payments to Acquire Property, Plant, and Equipment $766,000 USD 443%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $409,070,000 USD -161%
Lessee, Operating Lease, Liability, to be Paid $42,745,000 USD -31%
Property, Plant and Equipment, Gross $70,890,000 USD 4%
Operating Lease, Liability, Current $18,392,000 USD 9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,755,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $18,511,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.057 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,538,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,479,000 USD -83%
Deferred Tax Assets, Operating Loss Carryforwards $134,116,000 USD 406%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $35,789,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,479,000 USD -83%
Operating Lease, Payments $19,583,000 USD 4.7%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $52,552,000 USD 23%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%